北京百益宁医学科技有限公司由原301医院普外研究所团队组建,重点布局肿瘤精准免疫治疗市场与相关科学研究。公司技术团队平行移植了原301医院普外研究所技术团队以及多种肿瘤免疫细胞治疗技术(包括自体肿瘤抗原、DC、TIL、细胞因子等综合免疫状态评估技术),并在此基础上研发出鉴定与筛选特异性的肿瘤新抗原技术(Neoantigen)。百益宁医学技术团队拥有20多年的肿瘤免疫细胞治疗技术沉淀,积累了几十万例临床样本数据,处于...
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows